Focused Registry on the Titanium Trochanter Fixation Nail Advanced (TFNAdvanced™)
Sponsored by AO Clinical Investigation and Publishing Documentation
About this trial
Last updated 5 years ago
Study ID
Status
Type
Placebo
Accepting
Not accepting
Trial Timing
Ended 8 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Age 18 years and older
- Pertrochanteric femoral fracture (31-A1 and 31-A2), intertrochanteric fracture (31-A3), fracture of the trochanteric area (31-A1/A2/A3) with diaphyseal extension or combined fracture of the trochanteric area and the femoral shaft (32-A/B/C) treated with the TFNA system according to the technique guide
- Ability to understand the content of the patient information / informed consent form
- Willingness and ability to participate in the registry according to the registry plan (RP)
- Signed and dated IRB/EC-approved written informed consent or assent from a family member
Exclusion Criteria
- Additional acute fracture
- Any not medically managed severe systemic disease
- Recent history of substance abuse (i.e., recreational drugs, alcohol) that would preclude reliable assessment
- Pregnancy or women planning to conceive within the registry period
- Prisoner
- Participation in any other medical device or medicinal product registry within the previous month that could influence the results of the present registry
- Intraoperative decision to use implants other than the devices under investigation